chr4-113942550-T-C
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_024590.4(ARSJ):c.398+35887A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.811 in 151,926 control chromosomes in the GnomAD database, including 50,226 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.81   (  50226   hom.,  cov: 31) 
Consequence
 ARSJ
NM_024590.4 intron
NM_024590.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.135  
Publications
5 publications found 
Genes affected
 ARSJ  (HGNC:26286):  (arylsulfatase family member J) Sulfatases (EC 3.1.5.6), such as ARSJ, hydrolyze sulfate esters from sulfated steroids, carbohydrates, proteoglycans, and glycolipids. They are involved in hormone biosynthesis, modulation of cell signaling, and degradation of macromolecules (Sardiello et al., 2005 [PubMed 16174644]).[supplied by OMIM, Mar 2008] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98). 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.887  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| ARSJ | ENST00000315366.8 | c.398+35887A>G | intron_variant | Intron 1 of 1 | 1 | NM_024590.4 | ENSP00000320219.7 | |||
| ARSJ | ENST00000509829.1 | n.399-35805A>G | intron_variant | Intron 2 of 3 | 1 | ENSP00000421327.1 | ||||
| ARSJ | ENST00000636527.1 | n.399+27925A>G | intron_variant | Intron 3 of 3 | 5 | 
Frequencies
GnomAD3 genomes  0.811  AC: 123120AN: 151810Hom.:  50174  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
123120
AN: 
151810
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.811  AC: 123227AN: 151926Hom.:  50226  Cov.: 31 AF XY:  0.813  AC XY: 60311AN XY: 74226 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
123227
AN: 
151926
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
60311
AN XY: 
74226
show subpopulations 
African (AFR) 
 AF: 
AC: 
37113
AN: 
41498
American (AMR) 
 AF: 
AC: 
11950
AN: 
15216
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2425
AN: 
3462
East Asian (EAS) 
 AF: 
AC: 
4104
AN: 
5116
South Asian (SAS) 
 AF: 
AC: 
4015
AN: 
4816
European-Finnish (FIN) 
 AF: 
AC: 
8505
AN: 
10580
Middle Eastern (MID) 
 AF: 
AC: 
243
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
52444
AN: 
67926
Other (OTH) 
 AF: 
AC: 
1695
AN: 
2106
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 1171 
 2342 
 3514 
 4685 
 5856 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 880 
 1760 
 2640 
 3520 
 4400 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2935
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.